Ipamorelin is a synthetic pentapeptide developed at Novo Nordisk and first described in 1998. It binds the ghrelin receptor (GHSR-1a), the same receptor as the earlier growth hormone releasing peptides, and was designed to be more selective for that receptor than they are.
It has mainly been studied in cell and animal models. Published human data is limited.
Technical details
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
|---|---|
| Formula | C38H49N9O5 |
| Molecular weight | 711.9 g/mol |
| CAS | 170851-70-4 |
| Form | Freeze-dried powder, 10 mg per vial |
| Research to date | Mostly cell and animal studies; limited human data |
Lab certificate
A third-party certificate of analysis for the current batch will be posted on this page once testing is complete.
Storage
Store the sealed vial in a freezer at around -20 °C, away from light and moisture.
For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic purposes.
